OCULUS INNOVATIVE SCIENCES I's ticker is OCLS and the CUSIP is 67575P207. A total of 20 filers reported holding OCULUS INNOVATIVE SCIENCES I in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $64,000 | -16.9% | 67,154 | -0.1% | 0.00% | – |
| Q4 2015 | $77,000 | -10.5% | 67,192 | +0.1% | 0.00% | – |
| Q3 2015 | $86,000 | +145.7% | 67,116 | +171.0% | 0.00% | – |
| Q2 2015 | $35,000 | +75.0% | 24,763 | +0.2% | 0.00% | – |
| Q1 2015 | $20,000 | -42.9% | 24,725 | +0.5% | 0.00% | – |
| Q4 2014 | $35,000 | -38.6% | 24,611 | +0.5% | 0.00% | – |
| Q3 2014 | $57,000 | -3.4% | 24,497 | +27.2% | 0.00% | – |
| Q2 2014 | $59,000 | -18.1% | 19,257 | -0.2% | 0.00% | – |
| Q1 2014 | $72,000 | – | 19,295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|